Company & Sponsor Intelligence

Ain Shams University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting1

Completed5

Countries1

Therapeutic footprint

adhdanxietyautismepilepsymigraine_headacheother_neurologyparkinsons

Indexed studies

NCT02550912A Study Evaluating the Effect of Vitamin D on Clinical Outcome in Autistic Children
autism · EgyptPHASE2

NCT05039996Effectiveness of Education and Relaxation Program on Migraine Related Disability in Patients Attending Headache Clinic
migraine_headache · EgyptNA

NCT05670509Intranasal vs Buccal vs Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures
epilepsy · EgyptPHASE4

NCT06542887Black Seed Oil in ADHD
adhd · PHASE2

NCT06606899A Comparison Between Oral Melatonin With Nasal Sevoflurane Versus Oral Chloral Hydrate With Nasal Sevoflurane in Sedation of Children Undergoing Brain MRI
other_neurology · EgyptNA

NCT06255873Effects of L-Carnitine on Gastric Emptying in Children With Drug Resistant Epilepsy on Ketogenic Diet
epilepsy · EgyptNA

NCT07138391Chamomile Gummies and Pediatric Dental Anxiety
anxiety · EgyptPHASE2,PHASE3

NCT04308135Differences Between Patients With Vascular Parkinsonism and Parkinson's Disease
parkinsons · EgyptCOMPLETED

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →